CN
Mobile Site
Search
Sunshine and health are two important elements in a high-quality life. Linuo Group, Wspecializing in ith solar power and healthcare branches industriesas its two development priorities, Linuo Group has been striving to develop itself steadily and to build a life of high quality for all peopleus all.
We will bring you the latest news. We may be separated by oceans and landmasses, but we share the fate of our planet. What happens in China, even in one corporation like Linuo Group, is relevant to all of us in one global marketplace and in one natural environment.
Linuo Group is a meeting of subsidiaries in several fast-growing sectors, but more importantly, is an integration of several historic companies, some a century old, with newly established high tech companies. This is probably a unique combination in China, inspiring all Linuo team members with tradition and innovation, while creating a special and respected brand.
Constant innovation is a key driver of corporate growth. Linuo Group places great emphasis on innovation in all areas of production, service, management and marketing. We are here to meet the needs of consumers in the new era and ceaseless innovation is crucial.
Linuo Group companies have taken quite different paths to lead them to the present day. Some are more than a century old, not something that can be said about many Chinese enterprises today, while others are newly founded high-tech companies. This makes for an interesting and mutually inspiring mix of Group members, contributing to a deep and meaningful Linuo brand.
· Do you want to design a better future?
· Then Linuo Group is for you!
Founded in 2004, Shandong Keyuan Pharmaceutical Co., Ltd. is the core member of Linuo Healthcare Industry. It is a high-tech company dedicated to the R&D, manufacture and sales of APIs. Its portfolio covers anti-diabetic agents, cardiovascular agents and anesthetics. Keyuan has established strategic partnership with many renowned international companies.
The company consistently upholds the entrepreneurship and practical working style. With the accumulative industrial strength and the technology-guided and people-oriented business principle, the company has gradually become the backbone of Shandong synthetic API industry.
The company produces gliclazide, metformin hydrochloride, isosorbide mononitrate, isosorbide dinitrate, isoclurance, ropivacaine hydrochloride and clarithromycin lactobionate.
Main accreditations: gliclazide, isosorbide monoitrate mixed powder and other products have obtained the accreditation of CEP. PLNS has obtained the accreditation of FDA.
In March 2016, Keyuan was listed on NEEQ. NEEQ varies the choice of investment and expands the withdrawal of venture investment institutions. Being listed on NEEQ provides more financing channels for the company, expanding the financing platform, and make the financing more flexible, which lays an increasingly solid foundation for the further development of the company and strengthens its international competitiveness. Keyuan will make itself a larger and stronger company with the help of the capital market.
Keyuan upholds the motto of Serving the country with industry and striving for excellence and is devoted to establishing the largest production base of anti-diabetic agents, cardiovascular agents and anesthetics for the benefit of the patients.